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The selective serotonin reuptake inhibitor fluoxetine significantly enhances adult visual
cortex plasticity within the rat. This effect is related to decreased gamma-aminobutyric
acid (GABA) mediated inhibition and identifies fluoxetine as a potential agent for
enhancing plasticity in the adult human brain. We tested the hypothesis that fluoxetine
would enhance visual perceptual learning of a motion direction discrimination (MDD)
task in humans. We also investigated (1) the effect of fluoxetine on visual and motor
cortex excitability and (2) the impact of increased GABA mediated inhibition following
a single dose of triazolam on post-training MDD task performance. Within a double
blind, placebo controlled design, 20 healthy adult participants completed a 19-day
course of fluoxetine (n = 10, 20 mg per day) or placebo (n = 10). Participants were
trained on the MDD task over the final 5 days of fluoxetine administration. Accuracy for
the trained MDD stimulus and an untrained MDD stimulus configuration was assessed
before and after training, after triazolam and 1 week after triazolam. Motor and visual
cortex excitability were measured using transcranial magnetic stimulation. Fluoxetine
did not enhance the magnitude or rate of perceptual learning and full transfer of
learning to the untrained stimulus was observed for both groups. After training was
complete, trazolam had no effect on trained task performance but significantly impaired
untrained task performance. No consistent effects of fluoxetine on cortical excitability
were observed. The results do not support the hypothesis that fluoxetine can enhance
learning in humans. However, the specific effect of triazolam on MDD task performance
for the untrained stimulus suggests that learning and learning transfer rely on dissociable
neural mechanisms.
Keywords: motion perception, serotonin uptake inhibitors, learning, TMS, mood, phosphene threshold, motor
threshold, paired associative stimulation (PAS)
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INTRODUCTION
Visual perceptual learning (VPL) is an established model of
adult human brain plasticity that involves improved visual task
performance with training (Epstein, 1967; Gibson, 1969, 1991;
Watanabe and Sasaki, 2015). VPL can be highly specific to the
trained stimulus configuration (Ball and Sekuler, 1982). This
implies the involvement of neural populations in visual areas
such as V1, V2, V4, and the middle temporal area (MT) that
are tightly tuned to orientation, retinal location and motion
direction (Fiorentini and Berardi, 1980; Ball and Sekuler, 1982,
1987; Karni and Sagi, 1991; Gilbert, 1994). The involvement of the
primary and extrastriate visual cortex in VPL has been supported,
in part, by primate neurophysiology (Zohary et al., 1994; Crist
et al., 2001; Schoups et al., 2001; Ghose et al., 2002; Li et al.,
2004, 2008; Rainer et al., 2004; Yang and Maunsell, 2004; Raiguel
et al., 2006; Hua et al., 2010; Adab and Vogels, 2011; Yan et al.,
2014) and human neuroimaging studies (Schiltz et al., 1999, 2001;
Schwartz et al., 2002; Furmanski et al., 2004; Walker et al., 2005;
Yotsumoto et al., 2008; Bao et al., 2010; Shibata et al., 2011,
2012; Thompson et al., 2013; Bi et al., 2014). However, transfer
of learning to untrained stimuli and tasks can occur (Ahissar
and Hochstein, 1997; Liu, 1999; Liu and Weinshall, 2000; Xiao
et al., 2008; Jeter et al., 2009; Green et al., 2015) indicating that
higher-level decision making areas are also involved in VPL.
In agreement with this idea, primate neurophysiological data
have revealed learning induced changes within the decision-
making area LIP (lateral intraparietal sulcus) but not in MT
following motion discrimination VPL (Law and Gold, 2008).
Neuromodulation and fMRI studies in humans have also shown
that VPL involves decision-making areas (Kahnt et al., 2011;
Chen et al., 2015, 2016).
In accordance with evidence suggesting that VPL involves
multiple cortical areas, some current VPL models propose
changes at more than one stage of visual processing or type
of stimulus representation (Dosher et al., 2013; Watanabe and
Sasaki, 2015). For example, Watanabe and Sasaki (2015) suggest
that perceptual learning of a trained task involves changes in
the representation of stimulus features, possibly within visual
cortex, as well as changes in task-specific visual processing that
may involve decision making areas. Within this schematic model,
transfer of learning to an untrained stimulus location may involve
task-specific changes only (Watanabe and Sasaki, 2015).
Visual perceptual learning has been used as a model to
investigate the effects of neuromodulatory interventions on
adult brain plasticity. Interventions that enhance VPL include
transcranial random noise stimulation (Fertonani et al., 2011)
and the administration of donepezil to increase the synaptic
concentration of acetylcholine (Rokem and Silver, 2010, 2013).
Enhanced VPL was also found in patients with increased
glutamatergic transmission due to Huntington’s disease (Beste
et al., 2012). These studies demonstrate that altered cortical
function can enhance VPL.
Pharmacological manipulations have also been used to
increase visual cortex plasticity in animal models (Bavelier et al.,
2010). In an influential study, Maya Vetencourt et al. (2008)
found that chronic administration of the selective serotonin
reuptake inhibitor (SSRI) fluoxetine dramatically enhanced visual
cortex plasticity in adult rats, effectively ‘reopening’ the critical
period for visual cortex development. Plasticity was linked to
an increased concentration of brain derived neurotrophic factor
(BDNF) and a reduction in visual cortex gamma-aminobutyric
acid (GABA) concentration. Increasing GABA with diazepam
blocked the plasticity enhancing effects of fluoxetine. This result
suggested that fluoxetine might be beneficial in the treatment of
neurological vision disorders such as amblyopia in adult patients.
Selective serotonin reuptake inhibitors may also increase
cortical plasticity in humans. Normann et al. (2007) reported that
the SSRI sertraline enhanced the effect of a visual stimulation
protocol designed to induce long-term potentiation (LTP) in the
human primary visual cortex. Furthermore, SSRIs can enhance
motor cortex excitability and plasticity (Loubinoux et al., 1999,
2002a,b, 2005; Gerdelat-Mas et al., 2005). For example, a single
dose of citalopram induced acute increases in motor cortex
plasticity measured with paired associative stimulation (PAS), a
technique that utilizes transcranial magnetic stimulation (TMS)
paired with electrical stimulation of a peripheral nerve to induce
LTP like changes in cortical excitability (Bezchlibnyk-Butler et al.,
2000). Fluoxetine may also enhance the effects of physiotherapy
for stroke patients, possibly by increasing motor cortex plasticity
(Chollet et al., 2011).
The primary aim of this double blind, placebo-controlled
study was to assess whether a 3-week course of fluoxetine would
enhance VPL of a motion direction discrimination (MDD) task
(Ball and Sekuler, 1987) in visually normal adults. Our hypothesis
was that fluoxetine would enhance the rate, amount and transfer
of VPL by increasing visual cortex plasticity.
The study also involved a number of secondary aims. We
assessed the effect of SSRIs on visual and motor cortex excitability
by using TMS to measure phosphene and motor thresholds
(Deblieck et al., 2008). Acute changes in excitability were
measured 2 h after a single dose of citalopram, an SSRI with a
rapid onset of action (Bezchlibnyk-Butler et al., 2000). Chronic
changes in excitability were assessed during and after the course
of fluoxetine. Also, acute and chronic SSRI effects on motor
cortex plasticity were assessed using PAS. Finally, at the end of the
study, we delivered an acute dose of the benzodiazepine triazolam
to test the effect of increased GABA mediated inhibition on MDD
task performance (both trained task performance and transfer of
learning). Genotyping for BDNF was also conducted for a subset
of our participants because BDNF may influence an individual’s
response to interventions designed to modulate neuroplasticity
(Cheeran et al., 2010).
MATERIALS AND METHODS
Study Design
A double blind, placebo controlled experimental design was
adopted. Participants were randomized to the active or
placebo group by a computer-based random number generator
after recruitment to the study. Investigators were masked to
group allocations until data collection and processing were
complete.
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TABLE 1 | The study design.
Week 1 Week 2 Week 3 Week 4 Week 5 Week 6
Monday S3: Baseline
MDD, TMS
S10: VPL
Tuesday S11: VPL End fluox/pla
Wednesday S12: Post VPL
MDD, TMS
Thursday S1: Prac
MDD, TMS
S4: Cital/pla
MDD, TMS
S5: Wk 1 MDD, TMS S6: Pre VPL MDD, TMS S14: Washout
MDD, TMS
Friday S2: Prac
MDD, TMS
Start fluox/pla S7: VPL S13: Triazolam
MDD, TMS
Saturday – S8: VPL
Sunday – S9: VPL
Prac, practice session; MDD, motion direction discrimination psychometric function measurements; TMS, transcranial magnetic stimulation measurements (phosphene
and motor thresholds); cital, citalopram; pla, placebo; fluox, fluoxetine, gray shading indicates daily doses of fluoxetine or placebo; VPL, visual perceptual learning training.
The Profile of Mood States Short Form Questionnaire was administered at every study visit.
The study design is shown in Table 1. Participants completed
14 study visits over a period of 6 weeks. The first two visits
were practice sessions in which participants were familiarized
with the psychophysical MDD task and the use of TMS to
measure visual and motor cortex excitability via phosphene
and motor thresholding techniques. Session 3 involved baseline
measurements and session 4 repeated these measures after an
acute dose of citalopram (active group) or placebo (placebo
group). Citalopram was chosen for the assessment of acute SSRI
effects because its peak plasma concentration is reached after
∼2 h rather than fluoxetine which takes in excess of 6 h. The
day after session 4 participants began their 19-day course of
once-daily fluoxetine (active group) or placebo (placebo group)
tablets. Fluoxetine was used for this section of the study because
it is has a longer half-life than citalopram (fluoxetine = 1–3 days
for an acute dose vs. 35 h for citalopram). This results in
consistent plasma concentrations and therefore more stable
pharmacodynamic effects. A 19-day course was provided because
the downstream auto-regulatory effects of the SSRIs take around
2 weeks to occur (Stahl, 1998). Measures were repeated on the
day of the 7th dose (session 5) and on the day of the 14th
dose (session 6). A course of five daily VPL sessions (sessions
7–11) began on the day of the 15th dose and ended on the
day of the 19th and final dose. Measures were made the day
after the final dose (session 12) and a blood sample was taken
for BDNF genotyping. Three days after the final fluoxetine dose
all participants (both active and placebo groups) were given
triazolam (time to peak plasma concentration ∼1 h, biological
half-life= 2 h) and measures were repeated 2 h later (session 13).
A final set of measures was collected 1 week after the triazolam
dose (session 14).
Participants
Twenty participants were recruited using posters and advertising
in and around the University of Auckland. Inclusion criteria:
male, right-handed [Edinburgh Handedness Questionnaire
(Oldfield, 1971) score greater than zero], 18–40 years of age,
normal or corrected-to-normal vision, no contraindications for
TMS. Exclusion criteria: self-reported personal or family history
of a mood disorder such as depression or bipolar disorder,
smoker, diabetes, history of: drug, alcohol or nicotine addiction,
use of medications or supplements known to alter mood; such
as St John’s Wort, history of seizures, post-graduate students
supervised by one of the researchers involved in the study. The
Northern X Ethics Board of New Zealand approved the study and
all study protocols compiled with the Declaration of Helsinki.
Right-handed males were recruited to reduce variability in
the measurement of motor cortex excitability due to handedness
or hormonal changes during the menstrual cycle. A psychiatrist
(SSRI eligibility) and a neurologist (TMS eligibility) reviewed
screening information prior to enrollment. Participants were paid
$600 in vouchers and were asked to refrain from taking caffeine
on test days and avoid the use of recreational drugs (except
alcohol) during the study. A urine test was administered as part
of session 12 to screen for recreational drug use. No participants
failed the test. Regular telephone contact was maintained with
participants to ensure that they did not experience any adverse
drug effects and to encourage compliance with the study protocol.
Drug Prescription
Active or placebo tablets (1 × 20 mg citalopram and 19 × 20 mg
fluoxetine or 20 ×methylcellulose) were dispensed in unmarked
blister packs by an unmasked pharmacist. A 3-week course was
chosen to limit the exposure of our participants to SSRIs. All
participants were given 0.0625 mg of triazolam at the start of
session 14. The citalopram and triazolam doses were taken 2 h
before testing. Fluoxetine doses were taken at breakfast.
Motion Direction Discrimination
Participants fixed on a central point and judged whether the
motion direction of two consecutively presented dot fields was
the same or different (Ball and Sekuler, 1987; Liu, 1999). The
stimulus contained 400 dark dots (0.1◦) randomly distributed
within a light gray 8◦ circular aperture (65 cm viewing distance).
During each stimulus presentation, the dots moved coherently
above or below a fixed motion orientation, which was either
toward the top right hand corner (315◦ orientation) or the top
left hand corner of the screen (225◦ orientation) at 10◦/s. If
the stimuli moved in different directions, one direction was
always above the fixed motion orientation and one was below.
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Therefore, the motion stimulus had two direction components,
a motion orientation and a motion direction (Figure 1). The
motion orientation bisected the two motion directions shown
within a trial. Task difficulty was manipulated by varying the
angular difference between the two directions shown in a trial.
Psychometric functions were measured without feedback
separately for each motion orientation during sessions 3–6 and
12–14. A psychometric function for one motion orientation
consisted of 140 trials for each of five angular differences (12◦,
10◦, 8◦, 6◦, and 4◦) that were presented in a random order (700
trials total). A Weibull function was fitted to the resulting data for
each motion orientation to provide an estimate of the 75% correct
threshold angular difference.
Participants were familiarized with the task in sessions 1 and
2 by performing 40 trials at an angular difference of 15◦ with
visual feedback until they reached 90% accuracy for both motion
orientations. Two psychometric function measurements were
then completed with feedback, one for each motion orientation.
Motion direction discrimination training occurred on sessions
7–11 and involved a daily block of 700 trials with feedback
presented at the 75% threshold measured on session 6 (the day
before training). Only one motion orientation was trained. The
motion orientation to be trained was randomly assigned to each
participant prior to active or placebo group randomization.
Mood
The Profile of Mood State – Short Form questionnaire (POMS-
SF), and the Depression, Anxiety and Stress Scale (DASS-21) were
administered at the initial screening and consent visit as part of
the eligibility criteria assessment. The POMS-SF was completed at
every session to test for any SSRI-induced changes in mood. The
Total Mood Disturbance score (TMD = [Tension + Depression
+ Anger + Fatigue + Confusion] – Vigor) was used for analysis
(McNair et al., 1971).
Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation measures of visual and motor
cortex excitability were made on sessions 1–6 and 12–14 using
a MagStim 200 stimulator and a flat, 70 mm figure of eight coil.
PAS was delivered using a MagStim Rapid 2 stimulator equipped
with a 70 mm double air film coil and a Grass S48 direct current
stimulator with a constant current unit (CCU5) was used for
median nerve stimulation.
Phosphene Thresholds
Participants wore lightproof goggles and were instructed to keep
their eyes open, while gazing straight ahead. Single-pulse TMS
was delivered with the coil handle oriented upward. The coil
center was positioned 2 cm above the inion, and the coil position
was altered in 1 cm steps in a grid pattern until the optimal
position for eliciting a phosphene was determined. Stimulation
began at 30% maximum stimulator output (MSO) and was
increased until a phosphene was observed reliably. If 100% MSO
was reached on two attempts without phosphene perception
the procedure was terminated. Phosphenes were verified by
ensuring that they occurred in the hemifield contralateral to the
stimulated hemisphere. The phosphene threshold was defined as
the minimum intensity that produced a phosphene on four out of
eight consecutive TMS pulses.
In addition to a standard phosphene threshold, a new
measure of perceived phosphene intensity was used to quantify
any SSRI-induced changes in the suprathreshold phosphene
stimulus-response function. A stimulus intensity range was
calibrated using the immediately preceding phosphene
threshold measurement. Ranges were 40–80, 50–90, or 60–
100% MSO with pulses delivered at 10% MSO intervals
within the range. The range with the lower bound closest
to (but exceeding) the phosphene threshold was chosen on
a session-by-session basis. First, a pulse with the strongest
strength in the range was delivered to the phosphene hotspot
to generate a reference phosphene. Participants rated the
strength of all subsequent phosphenes relative to the reference
using a visual analogue scale (VAS). Each of the five pulse
strengths was repeated five times in a random order. Perceived
intensity was calculated by measuring the distance between
the start of a VAS line and the bisection drawn by the
participant in mm. Data from each session were fit with a
logistic function to provide a 50% of maximum intensity
FIGURE 1 | A schematic of the motion direction discrimination task. The gray arrows show the motion orientation and the small black arrows individual dot
directions. Participants judged whether two consecutively presented dot fields moved in the same or different directions. The arrows are for illustration purposes only.
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threshold. Thresholds exceeding 100% MSO were set to 100%
MSO.
Resting Motor Threshold
Electromyography (EMG) was recorded in a standard manner
by using electrodes placed on the abductor pollicis brevis (APB)
muscle and the first dorsal interosseous (FDI) muscle, of the
relaxed right hand. Rest motor threshold (RMT) was determined
for the FDI muscle to the nearest 1% of stimulator output as the
lowest stimulus intensity that produced an MEP > 50 µV in at
least four of eight trials (Rossini et al., 1994).
Paired Associative Stimulation
Motor cortex excitability was assessed pre- and post-PAS by
measuring stimulus response curves for both the APB and FDI
muscles. Single pulse TMS was delivered in pseudo randomized
blocks of 10 trials at stimulation intensities of 40, 50, 60, 70,
and 80% MSO. For each trial, peak to peak MEP amplitude
was determined within a 10–45 ms window following TMS. Pre-
TMS root mean square EMG activity was recorded for 100 ms
prior to each TMS pulse to ensure that the muscles were at rest.
The MEP amplitudes within a block were ranked and the mean
MEP amplitude for the central six MEPs was calculated. A linear
function was then fit to the means of the five blocks within a
session and the slope of the function was used as a measure of
excitability. The ratio of pre to post PAS slopes (post/pre) was
used for analysis.
The PAS protocol involved direct current stimulation of the
right median nerve combined with motor cortex TMS. Median
nerve stimulation had an intensity of three times the participant’s
sensory detection threshold and was delivered in bursts of 10
pulses at 30 Hz. Bursts of median nerve stimulation were paired
with TMS of the APB hotspot once every 1.1 s. TMS was delivered
at 100% of RMT. The PAS protocol delivered 180 pairs of stimuli
(Stefan et al., 2002) and lasted 200 s.
BDNF Polymorphisms
Participants were asked to provide a blood sample at the end
of session 12. The sample was processed to identify single-
nucleotide polymorphisms (SNP) for BDNF. Participants could
opt out of the blood sample and still remain eligible for the
study. Genotyping was undertaken using the Agena MassArray
iPLEX assay (Agena Bioscience, San Diego, CA, USA). Analysis
using the Bruker Mass Spectrometer was then conducted using
parameters optimized for iPLEX chemistry allowing allele specific
single base extensions to be resolved. Visual quality checks were
made of the generated peaks in addition to the non-template
control prior to report generation using Typer 4 analysis software
(Agena Bioscience).
RESULTS
Twenty participants completed the study, 10 active (mean
age 24.5 years, ±6.1) and 10 placebo (24.5, ±5.5 years).
Three eligible participants withdrew from the study prior to
randomization due to the time commitment required. Three
participants (two active and one placebo) did not attend session
4 due to mild illnesses such as colds. The drug dose was still
taken. BDNF polymorphisms were available for 14 participants
(seven per group). Both groups included participants with
each possible BDNF polymorphism (Placebo; 3 val66, 1 met66,
and 3 val66met, Active; 4 val66, 1 met66, and 2 val66met).
ANOVA analyses were Huynh-Feldt corrected for sphericity
where necessary.
Visual Perceptual Learning
Fluoxetine and Learning
A mixed ANOVA with factors of treatment group (active
vs. placebo) and training session (five levels; sessions 7–
11), was conducted on the percent correct scores. Accuracy
improved across sessions for both groups (F3,47 = 11.4,
p < 0.001; Figure 2A). However, there was no interaction
between session and treatment group (F3,47 = 0.51, p = 0.7)
indicating that the rate and magnitude of learning did not
differ between the two groups. To confirm this, linear functions
were fit to each participant’s learning curve and the slopes
were compared between the active and placebo groups. The
mean slope for the active group (1.7, ±1.2) did not differ
from the placebo group (1.8, ±2.4), t18 = 0.1, p = 0.9.
In addition, exponential functions were fit to the error rate
curves for each participant and the model parameters were
compared between the active and placebo groups. No significant
differences were found between the two groups (all t > 1.1,
all p > 0.1). A separate ANOVA with an additional between
subjects factor of BDNF polymorphism (n = 14) revealed no
main effects or interactions involving BDNF polymorphism (all
p > 0.05).
To determine the specificity of learning for the trained motion
orientation, psychometric functions before (session 6) and after
(session 12) training were compared. A mixed ANOVA with
factors of treatment group, session (pre-training, post-training)
and motion orientation (trained, untrained) was conducted
on the angular threshold data. Learning significantly reduced
thresholds (F1,18 = 22.6, p < 0.001) but the extent of this
learning was not influenced by group or motion orientation (all
interactions p > 0.05; Figure 2B). These results demonstrate a
full transfer of learning from the trained motion orientation to
the untrained motion orientation that did not differ significantly
between the two groups.
Acute Effect of Citalopram on Motion Direction
Discrimination
Angular thresholds derived from psychometric function
measurements were compared between the baseline session
(Session 3) and the acute citalopram session (Session 4). The data
were collapsed across motion orientation as training had not yet
taken place. A repeated measures ANOVA with factors of session
(baseline and acute citalopram) and group (placebo vs. active)
revealed that citalopram had no acute effect on task performance.
There was no significant main effect of session (F1,15 = 1.3,
p = 0.3), between-subjects effects of group (F1,15 = 195.5,
p= 0.3) or interaction (F1,15 = 3.8, p= 0.07).
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FIGURE 2 | The effect of fluoxetine on visual perceptual learning (VPL). (A) Group mean trained task percent correct for the placebo and active groups as a
function of training session (S7–S11: Table 1). Task difficulty was fixed at the pre training 75% correct threshold. (B) 75% correct angular difference thresholds for
the trained and untrained motion orientations from psychometric function measurements made pre (S6) and post (S12) training (Table 1). Error bars show SEM.
Asterisks denote statistically significant main effects of training (p < 0.05) see main text for details.
Triazolam and Post-training Motion Direction
Discrimination
Angular thresholds were compared the day before (session
12), 2 h after (session 13), and the 1-week after (session 14)
triazolam administration. Two participants were excluded from
this secondary analysis (one from each group) as they did
not demonstrate learning over the 5-day training period and
therefore the effect of triazolam on improved task performance
could not be measured. These two participants showed no
improvement in task performance between the first and last
training session and linear functions fitted to their training data
were negative.
A mixed ANOVA with factors of session (post-training,
triazolam, and washout), training orientation (untrained and
trained) and group (active and placebo) was conducted on
the angular difference thresholds. Only the interaction between
training orientation and session was significant (F2,32 = 3.4,
p = 0.04). Paired samples t-tests conducted on the angular
difference thresholds collapsed across group demonstrated that
triazolam impaired MDD for the untrained orientation only
(Figure 3).
Cortical Excitability
Thirteen participants (eight placebo, five active) perceived
phosphenes and were included in the phosphene threshold
analyses. One participant from the placebo group had a missing
data point (S4) that was imputed using the last observation
carried forward method. For standard phosphene thresholds,
a mixed ANOVA with factors of session (seven sessions: 3–
6 and 12–14) and group (placebo and active) revealed a
significant main effect of session (F4,43 = 5.8, p = 0.001)
indicating a systematic reduction in phosphene threshold over
time (Figure 4A). There was no session by group interaction
(F4,43 = 2.0, p = 0.11). A close inspection of the data
(Figure 4) suggested a trend for a larger decrease in threshold
for the active group across sessions. The active group had
significantly lower thresholds than the placebo group on
session 13 (t11 = 2.7, p = 0.02) and session 14 (t11 = 3.3,
p= 0.01).
A similar pattern of results was evident for the suprathreshold
phosphene intensity rating measurements (Figure 4B).
Thresholds significantly decreased over consecutive sessions
(F6,66 = 3.1, p = 0.008) indicating an increase in cortical
excitability. This effect differed significantly between the two
groups (significant interaction between treatment group and
session, F6,66 = 2.5, p= 0.03). The placebo group did not exhibit
a significant change over consecutive sessions (F6,42 = 0.3,
p = 0.9), whereas the active group did (F6,24 = 7.1, p < 0.001).
The groups differed significantly at sessions 13 (t11 = 2.1,
p= 0.04) and 14 (t11 = 2.4, p= 0.04).
Resting motor thresholds were stable across all sessions
(F6,108 = 0.72, p= 0.6) and did not differ between the two groups
for any session (p > 0.05; Figure 5A).
Mood
Six participants in the placebo group and four participants in the
active group had one missing POMS score due to an absence or
incorrect completion of the questionnaire. These missing data
points were imputed using the last observation carried forward
when possible. If the S3 data point was missing, the S4 data
point was carried backward. The POMS-SF TMD score did
not vary significantly across sessions (F4,73 = 0.71, p = 0.6)
and there was no session by group interaction (F4,73 = 1.36,
p = 0.2; Figure 5B). This was also the case when the analyses
were repeated without imputation for missing values. Therefore,
consistent with previous work, (Gelfin et al., 1998) [but see
(Serretti et al., 2010)] fluoxetine did not alter mood in our healthy
participants.
Paired Associative Stimulation
There was considerable variability in the response to PAS
(Figure 6). Significant PAS induced facilitation was not observed
at baseline for either muscle (APB or FDI) or post PAS time point
(5 and 20 min post PAS), all t < 1.2, all p > 0.25. The placebo
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FIGURE 3 | The effect of triazolam on trained and untrained task performance after learning was complete. There was complete transfer of learning from
pre (S6) to post (S12) training. Only learning transfer was affected by triazolam (S13). Thresholds had returned to post training levels 1 week after triazolam (washout;
S14). Error bars show SEM. Asterisks depict statistically significant effects of triazolam (p < 0.05).
FIGURE 4 | Visual cortex excitability as a function of session for participants who perceived phosphenes within the placebo (n = 8) and active (n = 5)
groups. (A) Phosphene thresholds. (B) Suprathreshold phosphene intensities corresponding to 50% of maximum intensity. Units are % maximum stimulator output
(MSO). Sessions: baseline = S3, citalopram = S4, Post 1 week = S5, Pre Training = S6, Post Training = S12, Triazolam = S13, Washout = S14. Asterisks indicate
statistically significant differences between the active and placebo groups (p < 0.05).
and active groups did not differ significantly across sessions
for either post PAS time point for either muscle (all F < 1.8,
all p > 0.1). There were no interactions between group and
session (all F < 0.2, all p > 0.2). A sub-analysis including only
participants for whom BDNF polymorphism data were available
revealed no interaction between BDNF polymorphism and group
(all F < 0.6, all p > 0.4). A separate analysis of the pre and post
citalopram data (session 3 vs. session 4) revealed no significant
interaction between session and group for either the 5 min
post PAS (F1,15 = 0.2, p = 0.7) or the 20 min post PAS data
(F1,15 = 1.6, p= 0.2).
DISCUSSION
Our primary hypothesis was that fluoxetine would increase the
rate and magnitude of VPL compared to placebo in observers
with normal vision. This hypothesis was not supported. The
active and placebo groups did not differ significantly in any of the
metrics of VPL that we investigated. However, increased GABA-
mediated inhibition due to an acute dose of triazolam was found
to selectively impair improved MDD that was due to learning
transfer. This suggests that training and transfer effects induced
by VPL rely on dissociable neural mechanisms.
Studies designed to pharmacologically manipulate learning
are faced with a large parameter space in terms of drug dosing.
Our choice of 20 mg per day for 3 weeks was driven by
a desire to give the minimum clinically effective dose for a
period of time that does not typically affect mood. However,
it is possible that larger doses or longer courses of fluoxetine
would enhance learning. Prior studies on rats have used high
doses of fluoxetine to induce plasticity (Maya Vetencourt
et al., 2008). It is also possible that SSRIs may have a greater
influence on visual cortex plasticity in patients with visual
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FIGURE 5 | Resting motor threshold (A) and Profile of Mood States Short Form (POMS) Total Score (B) as a function of session for the placebo and
active groups. Resting motor thresholds are expressed in units of % MSO and were assessed on sessions 3–6 and 12–14 (Table 1). POMS scores were collected
on every session. Error bars show SEM.
FIGURE 6 | The effect of PAS on motor cortex excitability across sessions for the placebo and drug groups. PAS data are shown as linear slope of the
stimulus response curve post/pre ratios. Ratios of 1 indicate no change, >1 indicates facilitation, <1 indicates suppression. APB, abductor pollicis brevis muscle;
FDI, first dorsal interosseous muscle; 5 m, 5 min post PAS; 20 m, 20 min post PAS. Error bars show SEM.
disorders such as amblyopia. A greater propensity for perceptual
learning has been reported in such patients (Huang et al.,
2008). Finally, we may not have had sufficient statistical power
to detect a difference in learning between the two treatment
groups. However, our data do not show any trends that are
indicative of an effect of fluoxetine on learning suggesting
that increasing statistical power may not have changed our
results.
We observed a complete transfer of learning to the untrained
motion orientation after 5 days of training. This was unexpected
based on previous studies using the same task (Ball and
Sekuler, 1987). Two factors are likely to have contributed to
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this transfer. Firstly, participants were tested extensively on
both motion orientations prior to training over the course
of five psychometric function measurements per orientation.
Each measurement consisted of 700 trials. Familiarization to
both motion orientations also occurred in the initial practice
sessions. This procedure ensured a stable pre-training baseline
measure for both motion orientations. Pre-training or double
training has previously been found to prime transfer to untrained
stimulus features (Xiao et al., 2008) including an untrained
motion direction (Zhang and Yang, 2014). Our psychometric
function measurements may have acted to prime transfer to the
untrained motion orientation. Second, we trained participants at
a fixed angular difference that corresponded to their 75% correct
threshold pre training and allowed accuracy to improve. This
meant that the task became easier and required less precision.
Training on easier tasks (Liu, 1999) results in greater learning
transfer and transfer is greater to tasks that do not require
high precision judgments (Jeter et al., 2009). In addition, unlike
some previous studies, (Liu and Vaina, 1998; Rokem and Silver,
2010) the corners of the monitor screen were visible to our
participants during stimulus presentation. Although the stimulus
was presented centrally and was 13.5◦ from the corners of the
screen, it is possible that the corners provided spatial cues that
aided learning transfer.
The complete transfer of learning between the trained
and untrained motion orientations enabled observation of an
unexpected effect of the benzodiazepine triazolam on MDD task
performance. Triazolam significantly impaired task performance
for the untrained motion direction (learning transfer) but not
the trained motion direction. To our knowledge, this is the
first pharmacological evidence for differential neural mechanisms
underlying learning and transfer in a VPL paradigm. The
differential effect of triazolam on learning and transfer is
consistent with current models of perceptual learning that
postulate a two-stage learning process for the trained task
(changes at both a sensory and decision making stage) and a
single stage learning process for transfer (changes at a decision
making stage only) (Watanabe and Sasaki, 2015). Triazolam
causes hyperpolarization of cells by allosteric modulation of
the GABA–A binding site and therefore inhibits neural activity.
Triazolam reduces the temporal sensitivity of vision (Maddock
et al., 1993) and similar benzodiazepines such as lorazepam
may impair visual processing and attention mechanisms (Giersch
et al., 1995; Giersch and Herzog, 2004; Michael et al., 2007). Our
data indicate that the neural mechanisms underlying VPL of the
trained stimulus are robust to the effects of triazolam whereas
those underlying learning transfer are not. This may reflect a
stronger effect of triazolam on higher-level areas that underpin
learning transfer compared to early sensory processing areas that
support trained task performance.
Selective serotonin reuptake inhibitors have been found to
increase cortical excitability (Loubinoux et al., 1999, 2002a,
2005; Gerdelat-Mas et al., 2005). We did not find significant
acute effects of citalopram on visual cortex excitability, however,
chronic administration of fluoxetine did appear to increase
excitability, particularly for the suprathreshold phosphene
intensity measure. However, the lack of a session by group
interaction effect for the phosphene threshold measure and
the fact that not all participants saw phosphenes preclude
strong conclusions being drawn. We found no evidence for
SSRI induced changes in resting motor threshold. This is
inconsistent with previous reports. For example, a single dose
of citalopram has been reported to transiently reduce motor
thresholds (Robol et al., 2004). Previous studies have compared
pre and post citalopram measures that were made on the same
day, whereas, we compared the post citalopram measurements to
measurements made 2 days prior. The added variability within
our design may have masked any small effect of citalopram on
motor cortex excitability.
We did not observe statistically significant PAS induced
facilitation of cortical excitability for the group in any session of
this study, nor did we observe any effect of SSRI administration.
There are considerable individual differences in the response to
PAS (Stefan et al., 2004; Cheeran et al., 2008; Cirillo et al., 2009,
2012; Huang et al., 2009; Missitzi et al., 2011; Witte et al., 2012)
and it is possible that our relatively small sample size did not
provide sufficient power to detect PAS effects. Alternatively, the
protocol utilized may not have been optimal to induce LTP-like
facilitation of cortical excitability.
In summary, we found no evidence for an enhancement of
motion VPL with fluoxetine. However, triazolam administration
impaired task performance for an untrained motion orientation
that exhibited learning transfer but not for the trained motion
orientation. This provides support for the theory that learning
and transfer of learning rely on dissociable neural mechanisms.
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